Effects of menopause and hormone replacement therapy on the associations of hyperuricemia with mortality

Atherosclerosis

Volumn 226, Issue 1, 2013, Pages 220-227

  Ioannou, George N ^a   Boyko, Edward J ^a  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

Cardiovascular mortality; Cohort study; Mortality; Population based; Serum uric acid

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; URIC ACID;

ADULT; ALBUMINURIA; ARTICLE; BODY MASS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; POSTMENOPAUSE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HORMONE REPLACEMENT THERAPY; HUMANS; HYPERURICEMIA; MENOPAUSE; MIDDLE AGED; RISK FACTORS; URIC ACID;

EID: 84871391715     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.10.044     Document Type: Article

References (31)

1. Feig D.I., Kang D.H., Johnson R.J. Uric acid and cardiovascular risk. N Engl J Med 2008, 359:1811-1821.
2. Edwards N.L. The role of hyperuricemia in vascular disorders. Curr Opinion Rheumatol 2009, 21:132-137.
3. Niskanen L.K., Laaksonen D.E., Nyyssonen K., et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 2004, 164:1546-1551.
4. Fang J., Alderman M.H. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000, 283:2404-2410.
5. Strasak A.M., Kelleher C.C., Brant L.J., et al. Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study. Int J Cardiol 2008, 125:232-239.
6. Holme I., Aastveit A.H., Hammar N., Jungner I., Walldius G. Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med 2009, 266:558-570.
7. Meisinger C., Koenig W., Baumert J., Doring A. Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: the MONICA/KORA cohort study. Arterioscler Thromb Vasc Biol 2008, 28:1186-1192.
8. Wen C.P., David Cheng T.Y., Chan H.T., et al. Is high serum uric acid a risk marker or a target for treatment? Examination of its independent effect in a large cohort with low cardiovascular risk. Am J Kidney Dis 2010, 56:273-288.
9. Panero F., Gruden G., Perotto M., et al. Uric acid is not an independent predictor of cardiovascular mortality in type 2 diabetes: a population-based study. Atherosclerosis 2012, 221:183-188.
10. Culleton B.F., Larson M.G., Kannel W.B., Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999, 131:7-13.
11. Moriarity J.T., Folsom A.R., Iribarren C., Nieto F.J., Rosamond W.D. Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol 2000, 10:136-143.
12. Wannamethee S.G., Shaper A.G., Whincup P.H. Serum urate and the risk of major coronary heart disease events. Heart 1997, 78:147-153.
13. Wheeler J.G., Juzwishin K.D., Eiriksdottir G., Gudnason V., Danesh J. Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis. PLoS Med 2005, 2:e76.
14. Hak A.E., Choi H.K. Menopause, postmenopausal hormone use and serum uric acid levels in US women-the Third National Health and Nutrition Examination Survey. Arthritis Res Ther 2008, 10:R116.
15. Krishnan E., Svendsen K., Neaton J.D., Grandits G., Kuller L.H. Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med 2008, 168:1104-1110.
16. Kim S.Y., Guevara J.P., Kim K.M., Choi H.K., Heitjan D.F., Albert D.A. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2010, 62:170-180.
17. Sumino H., Ichikawa S., Kanda T., Nakamura T., Sakamaki T. Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia. Lancet 1999, 354:650.
18. Plan and operation of the third national health and nutrition examination survey, 1988-1994 1994, National Center for Health Statistics, Hyatsville, MD.
19. NCHS. NHANES III linked mortality file. Available at: [accessed 20.12.08]. http://www.cdc.gov/nchs/r%26d/nchs_datalinkage/nhanes3_data_linkage_mortality_public-use.htm.
20. NCHS The third national health and Nutrition examination survey (NHANES III) linked mortality file: matching methodology 2005, Available at:, [Accessed 20.12.08]. http://www.cdc.gov/nchs/data/datalinkage/matching_methodology_nhanes3_final.pdf.
21. Nash D., Magder L.S., Sherwin R., Rubin R.J., Silbergeld E.K. Bone density-related predictors of blood lead level among peri- and postmenopausal women in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol 2004, 160:901-911.
22. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
23. Coresh J., Astor B.C., McQuillan G., et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 2002, 39:920-929.
24. Hu F.B., Rimm E., Smith-Warner S.A., et al. Reproducibility and validity of dietary patterns assessed with a food-frequency questionnaire. Am J Clin Nutr 1999, 69:243-249.
25. Cox D.R. Regression models and life tables. J Royal Stat Soc Ser B 1972, 34:187-202.
26. Choi H.K., Ford E.S. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med 2007, 120:442-447.
27. Khosla U.M., Zharikov S., Finch J.L., et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005, 67:1739-1742.
28. Mercuro G., Vitale C., Cerquetani E., et al. Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol 2004, 94:932-935.
29. Barrett E.J., Eggleston E.M., Inyard A.C., et al. The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action. Diabetologia 2009, 52:752-764.
30. Sautin Y.Y., Nakagawa T., Zharikov S., Johnson R.J. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 2007, 293:C584-C596.
31. Frost C., Thompson S. Correcting for regression dilution bias: comparison of methods for a single predictor variable. J Royal Stat Soc Ser A 2000, 163:173-190.